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Cancer pathogenesis is associated with profound changes in 
cellular metabolism, but whether monitoring these changes can 
be used for real time diagnosis and therapy decision-making is 
largely unknown. The intelligent surgical knife (iKnife) 
allows for sampling of the aerosol ("smoke"), to detect the 
metabolomic composition of cauterized tissue via Rapid 
Evaporative Ionisation Mass Spectrometry (REIMS). This method 
has been used successfully for instantaneous classification of 
normal versus cancerous tissue, but the evolving metabolic 
landscape of tumour cells carries significantly more 
information than just the benign to malignant classification. 
Our data demonstrate that the iKnife allows for real time 
stratification of many clinically relevant features of breast 
cancer cells, including their stage, migration capacity, or 
exposure to metabolic conditions mimicking the tumour 
microenvironment. Of note, it also stratifies breast cancer 
into two major subtypes (lipogenic and non-lipogenic) with 
distinctive lipid signatures and overall lipid content. We 
demonstrate that this lipogenic subtype is highly enriched in 
PIK3CA mutations and depends predominantly on mTORC2 
activation, opening up opportunities to investigate the 
mechanistic basis underlying potential metabolic 
vulnerabilities. Overall, our findings show that iKnife 
couples metabolic rewiring with a novel mode of real time 
diagnosis of tumour characteristics, and highlight an 
unidentified role for mTORC2 activation in lipid biosynthesis 
that promotes aberrant growth in PIK3CA mutant tumours. 
 
